Virtual reality is transitioning from entertainment into the clinical toolkit, with FDA-cleared digital treatments now available for conditions like fibromyalgia and chronic pain. The medical VR space is consolidating rapidly, signaling that healthcare providers and insurers are beginning to view immersive therapy as a legitimate alternative to traditional care.

What Is Happening in Medical VR Right Now?

XR Health, a medical virtual reality platform, has acquired Swing Therapeutics, a company that developed an FDA-cleared digital treatment for fibromyalgia. This marks XR Health's sixth acquisition in the past two years, reflecting aggressive expansion in the digital therapeutics space. Fibromyalgia is a chronic condition characterized by widespread musculoskeletal pain, fatigue, and sleep disturbances, affecting millions of people worldwide. Swing's treatment has been cleared by the Food and Drug Administration (FDA), meaning it meets regulatory standards for safety and effectiveness.

The acquisition signals a broader industry trend: virtual reality is moving beyond meditation apps and wellness tools into prescription-grade medicine.

"It won't be the last" acquisition for the company, explained Eran Orr, CEO of XR Health, noting that the platform currently hosts dozens of different apps and delivered a million user sessions in 2025.

Eran Orr, CEO at XR Health

How Does VR-Based Treatment Work for Patients?

XR Health's platform offers a range of immersive experiences designed to address specific health conditions. Rather than simply providing distraction, these VR treatments are built on evidence-based therapeutic approaches. The platform includes cognitive behavioral therapy (CBT) based experiences, meditation programs, and pain management modules. Conditions currently targeted include mental health disorders, chronic pain, hot flashes, and other conditions where behavioral or cognitive intervention can help.

Swing's fibromyalgia treatment is primarily distributed through telehealth clinics, meaning patients can access the therapy remotely with clinical oversight. This hybrid model combines the convenience of digital health with professional medical guidance, addressing a key barrier to traditional in-person therapy: accessibility and scheduling flexibility.

What Makes VR Different From Other Digital Health Tools?

• FDA Clearance Status: Swing's fibromyalgia treatment has received FDA clearance, a regulatory milestone that distinguishes it from unregulated wellness apps. XR Health's larger packages of VR treatments are registered with the FDA but not yet cleared, indicating they are under regulatory review.
• Clinical Integration: Unlike consumer meditation apps, VR-based digital therapeutics are designed to be prescribed by healthcare providers and tracked as part of a patient's medical record, similar to traditional medications or therapy sessions.
• Immersive Engagement: Virtual reality creates a more immersive experience than smartphone apps or web-based programs, potentially increasing patient engagement and adherence to treatment protocols.

Why Is the Industry Consolidating Around VR?

The rapid acquisition pace in medical VR suggests that investors and healthcare companies believe immersive digital therapeutics represent the future of treatment delivery. XR Health's strategy of acquiring specialized developers like Swing allows the platform to expand its library of FDA-cleared treatments across multiple conditions. This approach mirrors how pharmaceutical companies acquire smaller biotech firms to diversify their drug portfolios.

The business model also reflects changing reimbursement landscapes. As insurance companies and Medicare increasingly cover digital therapeutics, the market for VR-based treatments is expanding. Telehealth clinics, which distribute Swing's fibromyalgia treatment, represent a distribution channel that bridges clinical credibility with patient convenience. This hybrid approach may be more attractive to payers than purely consumer-facing wellness apps, which lack clinical oversight.

The shift toward VR as medicine also addresses a practical healthcare challenge: the shortage of mental health providers and pain specialists. A VR-based treatment that can be delivered remotely and scaled across thousands of patients offers a way to extend clinical capacity without proportionally increasing the number of therapists or physicians needed.

What Does This Mean for Patients?

For people living with fibromyalgia, chronic pain, or mental health conditions, VR-based digital therapeutics may offer an additional treatment option. Unlike medications, which can carry side effects, or traditional therapy, which requires finding an available provider, VR treatments can be accessed at home with clinical oversight. The FDA clearance of Swing's fibromyalgia treatment suggests that at least one VR-based approach has demonstrated measurable clinical benefit in rigorous testing.

However, access will depend on whether healthcare providers prescribe these treatments and whether insurance plans cover them. The fact that Swing's treatment is distributed through telehealth clinics suggests that clinical gatekeeping remains in place, which may limit access for some patients but also ensures that treatments are used appropriately under professional guidance.

The broader implication is that digital health is maturing. The industry is moving beyond consumer wellness apps toward regulated, clinically validated treatments that can sit alongside traditional medicine in a patient's care plan. As more VR-based therapies receive FDA clearance and healthcare systems integrate them into clinical workflows, immersive technology may become as routine in medicine as stethoscopes and blood pressure monitors.